After the biotechs were slammed hard two months ago, many investors were freaked out and backed away from the group. However there is one company that has been one of the best performing stocks and has been talked about the least—which is precisely why Jim Cramer wanted to take a closer look.
United Therapeutics was founded by Dr. Martine Rothblatt, as a way to help to find a cure for pulmonary hypertension, a disease that ails her daughter. The company currently has four drugs on the market and an amazing pipeline that includes treatments for cardiopulmonary diseases, monoclonal antibody therapies that fight cancer, and glycobiology-based antiviral drugs.
Rothblatt has a history for backing edgy technological concepts. In 1990 she founded a company that was the first to use satellite frequencies that were assigned to television for the purpose of radio. At the time this was considered highly unusual, but the concept ultimately became Sirius XM Radio, which is now valued at $21 billion.
In 2013 Rothblatt was also ranked among the highest paid female executives in the United States, with a compensation of $38.2 million. According to her interview with Fortune she felt awkward from the attention received as being the highest paid female CEO, because she has only been a female for half of her life. In 1994 she underwent sex-reassignment surgery.